SG Americas Securities, LLC
Broker-DealerPosition in FATE — Fate Therapeutics Inc
CIK 1313360
NEW YORK, NY
Position in FATE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$85,301
-$10,865 QoQ
Shares Held
31,593
-60.6% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 156 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,086,395,205 across 182 Biotechnology names. FATE ranks #156 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in FATE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,301 | 31,593 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $96,166 | 80,139 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $38,134 | 38,913 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $18,774 | 14,900 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $58,914 | 52,602 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $27,256 | 34,502 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $74,042 | 44,874 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $120,270 | 34,363 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $119,300 | 36,372 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $274,927 | 37,456 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $338,668 | 90,553 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $156,121 | 73,642 | Shares | Sole | 2023-10-13 | |
| 2023-03-31 | $62,700 | 11,000 | Shares | Sole | 2023-04-28 | |
| 2022-06-30 | $324,023 | 13,076 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $4,059,412 | 104,705 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $24,585,316 | 420,190 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,355,511 | 56,614 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $4,606,032 | 53,071 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,459,282 | 17,699 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $261,787 | 2,879 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,088,521 | 77,271 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $151,341 | 4,411 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $564,911 | 25,435 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||